Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eli Lilly | Lima | Salute | Prodotti farmaceutici | 2,56 Bln PEN | 81,7x | 1,16 | 2.754,30 PEN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
UnitedHealth | Lima | Salute | Fornitori e servizi sanitari | 1,82 Bln PEN | 34x | -0,93 | 1.899,25 PEN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Johnson & Johnson | Lima | Salute | Prodotti farmaceutici | 1,32 Bln PEN | 24x | -0,44 | 554,65 PEN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
AbbVie | Lima | Salute | Prodotti farmaceutici | 1,12 Bln PEN | 59,1x | -2,78 | 709,36 PEN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Merck | Lima | Salute | Prodotti farmaceutici | 909,16 Mrd PEN | 20,1x | 0,12 | 356,96 PEN | -6,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Thermo Fisher Scientific | Lima | Salute | Attrezzature e forniture medicali | 818 Mrd PEN | 35,7x | 7,66 | 2.275,15 PEN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Abbott Laboratories | Lima | Salute | Attrezzature e forniture medicali | 786,67 Mrd PEN | 15,8x | 2,85 | 407,84 PEN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Danaher | Lima | Salute | Attrezzature e forniture medicali | 660,16 Mrd PEN | 46,1x | -1,29 | 938,15 PEN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Amgen | Lima | Salute | Prodotti farmaceutici | 552,14 Mrd PEN | 34,9x | -0,78 | 991,70 PEN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Pfizer | Lima | Salute | Prodotti farmaceutici | 552,09 Mrd PEN | 34,9x | -0,6 | 97,53 PEN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Bristol Myers Squibb | Lima | Salute | Prodotti farmaceutici | 440,65 Mrd PEN | -16,2x | 0,08 | 206,61 PEN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Gilead Sciences | Lima | Salute | Prodotti farmaceutici | 431,47 Mrd PEN | 918x | -9,28 | 339,12 PEN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Regeneron Pharmaceuticals | Lima | Salute | Ricerca medica e biotecnologica | 275,04 Mrd PEN | 15,8x | 1,03 | 3.980,10 PEN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
CVS Health | Lima | Salute | Fornitori e servizi sanitari | 253,33 Mrd PEN | 13,6x | -0,33 | 198,32 PEN | 0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Moderna | Lima | Salute | Ricerca medica e biotecnologica | 56,70 Mrd PEN | -6,7x | -0,17 | 145,91 PEN | -18,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |